Back to Search
Start Over
Atopy as Immune Dysregulation: Offender Genes and Targets.
- Source :
-
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2022 Jul; Vol. 10 (7), pp. 1737-1756. Date of Electronic Publication: 2022 Jun 06. - Publication Year :
- 2022
-
Abstract
- Allergic diseases are a heterogeneous group of disorders resulting from exaggerated type 2 inflammation. Although typically viewed as polygenic multifactorial disorders caused by the interaction of several genes with the environment, we have come to appreciate that allergic diseases can also be caused by monogenic variants affecting the immune system and the skin epithelial barrier. Through a myriad of genetic association studies and high-throughput sequencing tools, many monogenic and polygenic culprits of allergic diseases have been described. Identifying the genetic causes of atopy has shaped our understanding of how these conditions occur and how they may be treated and even prevented. Precision diagnostic tools and therapies that address the specific molecular pathways implicated in allergic inflammation provide exciting opportunities to improve our care for patients across the field of allergy and immunology. Here, we highlight offender genes implicated in polygenic and monogenic allergic diseases and list targeted therapeutic approaches that address these disrupted pathways.<br /> (Copyright © 2022 American Academy of Allergy, Asthma & Immunology. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2213-2201
- Volume :
- 10
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The journal of allergy and clinical immunology. In practice
- Publication Type :
- Academic Journal
- Accession number :
- 35680527
- Full Text :
- https://doi.org/10.1016/j.jaip.2022.04.001